Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Terminated 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Conditions

Neutropenia 5Neoplasms 4Febrile Neutropenia 4Fever 3Sezary Syndrome 2Precursor Cell Lymphoblastic Leukemia-Lymphoma 2Mycosis Fungoides 2Lymphoma, T-Cell, Cutaneous 2Lymphoma, Non-Hodgkin 2Lymphoma, Mantle-Cell 2Lymphoma, Large-Cell, Immunoblastic 2Lymphoma, Large B-Cell, Diffuse 2Lymphoma, Follicular 2Lymphoma, B-Cell, Marginal Zone 2Leukemia, Prolymphocytic 2Leukemia, Myelomonocytic, Chronic 2Leukemia, Myeloid, Acute 2Leukemia, Lymphocytic, Chronic, B-Cell 2Leukemia 2Hodgkin Disease 2Hematologic Neoplasms 2Burkitt Lymphoma 2Testicular Neoplasms 1Pseudomonas Infections 1Primary Myelofibrosis 1Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 1Pdgfra-Associated Chronic Eosinophilic Leukemia 1Other Infectious Diseases 1Neoplasms, Plasma Cell 1Myelodysplastic-Myeloproliferative Diseases 1

Interventions

ceftolozane, tazobactam drug combination 1ceftobiprole medocaril 1Vancomycin 1Cefepime 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Pseudomonas Infections × Cefepime × Clear all
NCT00529282 2012-08-01

A Study of Ceftobiprole in Patients With Fever and Neutropenia.

Basilea Pharmaceutica

Phase 3 Terminated
2 enrolled 4 charts

Fever, Neutropenia, Pseudomonas Infections, Gram-Positive Bacterial Infections

Data powered by HemOnc (CC BY 4.0) Colophon âš¡